Avantor (NYSE:AVTR – Get Free Report) will be announcing its earnings results before the market opens on Friday, July 26th. Analysts expect the company to announce earnings of $0.24 per share for the quarter. Investors interested in listening to the company’s conference call can do so using this link.
Avantor (NYSE:AVTR – Get Free Report) last announced its quarterly earnings data on Friday, April 26th. The company reported $0.22 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.20 by $0.02. The business had revenue of $1.68 billion during the quarter, compared to analysts’ expectations of $1.68 billion. Avantor had a return on equity of 13.01% and a net margin of 3.79%. The business’s quarterly revenue was down 5.6% compared to the same quarter last year. During the same quarter last year, the business posted $0.29 EPS. On average, analysts expect Avantor to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.
Avantor Stock Performance
Shares of AVTR opened at $22.35 on Thursday. The stock has a 50-day simple moving average of $22.42 and a 200-day simple moving average of $23.61. The company has a debt-to-equity ratio of 0.94, a quick ratio of 1.05 and a current ratio of 1.61. The stock has a market capitalization of $15.18 billion, a PE ratio of 57.31, a PEG ratio of 2.16 and a beta of 1.32. Avantor has a 1 year low of $16.63 and a 1 year high of $26.16.
Analyst Ratings Changes
Read Our Latest Stock Report on AVTR
Avantor Company Profile
Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.
Featured Stories
- Five stocks we like better than Avantor
- Health Care Stocks Explained: Why You Might Want to Invest
- Food Processing Company Stock Gets Fried by Recall: Time to Buy
- Want to Profit on the Downtrend? Downtrends, Explained.
- Entertainment Stock Offers A Rare and Tempting Entry Opportunity
- 3 REITs to Buy and Hold for the Long Term
- Will China’s Interest Rate Cuts Ignite a Rally for This Stock?
Receive News & Ratings for Avantor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avantor and related companies with MarketBeat.com's FREE daily email newsletter.